Omega-3 Fatty Acids: What are their roles in vascular protection?
June 15, 2020
Apply the evidence from omega-3 fatty acid trials to clinical practice in primary and secondary prevention.
- All
- Breaking News
- Presentation
- Webinar
- Accredited
- Non-Accredited
- Conference Video
- 6-Minute Consult
- Transformative Teachers
- Primary Care Physician
- Specialist
- Allied Health Professional
-
-
Cardiometabolic Update from the American Heart Association Scientific Sessions 2019
January 15, 2020Reviewing the emerging pharmacotherapies for heart failure and contemporary challenges in identifying and optimizing management of heart failure. -
It’s a New Day – A Breakthrough in Renal and Cardiac Benefits
April 27, 2019Discover key outcomes from 'It’s a New Day – A Breakthrough in Renal and Cardiac Benefits' -
Faire le lien entre diabète, insuffisance cardiaque et risque vasculaire Depuis la prévention jusqu’au traitement par des inhibiteurs du SGLT2 : intégration des nouvelles données probantes dans la pratique clinique
January 14, 2019Mettre en pratique le nouvel algorithme clinique pour utiliser un inhibiteur du SGLT2 chez les patients atteints d’une maladie vasculaire... -
Bridging the Gap between Diabetes, Heart Failure and Vascular Risk – From prevention to treatment with SGLT2i: Applying new evidence to clinical practice
January 14, 2019Discussing a new clinical algorithm to use SGLT2i in patients with vascular disease and heart failure -
Key Science at the EASD 2018: Implications for Practice
November 1, 2018Discover key scientific outcomes from EASD 2018 -
NOACS 2016
January 23, 2017Describe the recent developments in the management and treatment of atrial fibrillation. -
Diabetes CTU 2016
December 30, 2016National and international guideline updates with Dr. Amir K. Hanna, Individualizing therapy in 2016-2017 with Dr. Ronald M. Goldenberg, The... -
The PCSK9 Revolution in Cholesterol Reduction
June 6, 2016Understand the safety and efficacy of ultra-low LDL cholesterol in the secondary prevention of cardiovascular events. Discuss the evidence... -
SGLT2 Inhibitors Come of Age 2016
May 19, 2016Discuss the emerging role of SGLT2 inhibitors as a strategy for individualizing management of hyperglycemia in diabetes. -
Diabetes Clinical Trials Update 2016
April 27, 2016Gauge the burden of macrovascular and microvascular disease in diabetes. -
LUNG 2016
April 27, 2016Discuss the state-of-the-art updates in asthma, COPD and IPF, and describe guidelines vs. real life practice.
